The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-12
DOI
10.1038/s41598-019-47737-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery
- (2018) Lorna Ewart et al. Annual Review of Pharmacology and Toxicology
- The role of PNPLA3 in health and disease
- (2018) Piero Pingitore et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Genetics and epigenetics of NAFLD and NASH: Clinical impact
- (2018) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030
- (2018) Chris Estes et al. JOURNAL OF HEPATOLOGY
- Human hepatic 3D spheroids as a model for steatosis and insulin resistance
- (2018) Mikael Kozyra et al. Scientific Reports
- A simple approach for restoration of differentiation and function in cryopreserved human hepatocytes
- (2018) Magnus Ölander et al. ARCHIVES OF TOXICOLOGY
- TM6SF2 rs58542926 impacts lipid processing in liver and small intestine
- (2017) Elizabeth A. O'Hare et al. HEPATOLOGY
- Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis
- (2017) Nicole Ehrhardt et al. HUMAN MOLECULAR GENETICS
- Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD
- (2017) Panu K. Luukkonen et al. JOURNAL OF HEPATOLOGY
- Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
- (2017) P. Dongiovanni et al. JOURNAL OF INTERNAL MEDICINE
- Novel association of TM6SF2 rs58542926 genotype with increased serum tyrosine levels and decreased apoB-100 particles in Finns
- (2017) Daniel Seung Kim et al. JOURNAL OF LIPID RESEARCH
- Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci
- (2017) Stefan Stender et al. NATURE GENETICS
- Ensembl 2018
- (2017) Daniel R Zerbino et al. NUCLEIC ACIDS RESEARCH
- The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis
- (2017) Zhengtao Liu et al. Scientific Reports
- Hepatic Transmembrane 6 Superfamily Member 2 Regulates Cholesterol Metabolism in Mice
- (2016) Yanbo Fan et al. GASTROENTEROLOGY
- Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes
- (2016) Mohammed Eslam et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Inactivation ofTm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins
- (2016) Eriks Smagris et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
- (2016) Sven M. Francque et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances
- (2016) Jennie Ka Ching Lau et al. JOURNAL OF PATHOLOGY
- The Role of Cholesterol in the Pathogenesis of NASH
- (2016) George N. Ioannou TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease
- (2016) Catherine C. Bell et al. Scientific Reports
- Recent insights on the role of cholesterol in non-alcoholic fatty liver disease
- (2015) Graciela Arguello et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The application of engineered liver tissues for novel drug discovery
- (2015) Christine Lin et al. Expert Opinion on Drug Discovery
- Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
- (2015) Paola Dongiovanni et al. HEPATOLOGY
- Trimmomatic: a flexible trimmer for Illumina sequence data
- (2014) Anthony M. Bolger et al. BIOINFORMATICS
- Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk
- (2014) Oddgeir L Holmen et al. NATURE GENETICS
- Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
- (2014) Julia Kozlitina et al. NATURE GENETICS
- Animal models of human disease: Challenges in enabling translation
- (2013) Paul McGonigle et al. BIOCHEMICAL PHARMACOLOGY
- Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
- (2013) Yuki Kawano et al. JOURNAL OF GASTROENTEROLOGY
- The global NAFLD epidemic
- (2013) Rohit Loomba et al. Nature Reviews Gastroenterology & Hepatology
- Multi-cell type human liver microtissues for hepatotoxicity testing
- (2012) S. Messner et al. ARCHIVES OF TOXICOLOGY
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
- (2011) Bo Li et al. BMC BIOINFORMATICS
- Animal models of nonalcoholic fatty liver disease
- (2010) Lionel Hebbard et al. Nature Reviews Gastroenterology & Hepatology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started